FDA Inspection 1080590 — Shandong Lukang Shelile Pharmaceutical Co., Ltd.

Shandong Lukang Shelile Pharmaceutical Co., Ltd. — FEI 3001040579

The FDA completed an inspection of Shandong Lukang Shelile Pharmaceutical Co., Ltd. on December 14, 2018 in Jining. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 14, 2018
Fiscal Year
2019
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Jining (China)